Assessment and Improvement of Figures to Visually Convey Benefit and Risk of Stroke Thrombolysis
- 1 February 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 41 (2) , 300-306
Abstract
Background and Purpose— Deciding whether to use intravenous fibrinolytic therapy for acute cerebral ischemia within 3 hours of onset is challenging for patients, family members, and health care providers. Visual displays can permit individuals to rapidly understand response patterns to therapy. This study sought to evaluate, refine, and improve existing visual aids for stroke fibrinolytic decision-making. Methods— Existing visual aids were identified by Medline search and querying of national guideline organizations, pharmaceutical manufacturers, and stroke specialists, and were rated on a formal 8-point quality rating scale (0, lowest; 8, highest). Based on available instruments, new visual displays were developed to improve informed decision-making in routine practice. Results— Two existing visual aids were identified, one from an emergency medicine society and one from a pharmaceutical company. Both were comparison visual displays of outcomes with and without treatment; no decision matrix visual aid was found. Both scored 4.0 on the quality scale, showing defects of effect size distortion, privileging less salient outcomes, dissimilar representation by treatment group, and limited stakeholder participation in generation. Revised versions of these graphics were developed with higher quality scores (6.75 and 7.75). In addition, a new decision matrix display with quality score 8.0 was developed that complements the numeric text of a national patient education tool developed jointly by US neurology, emergency medicine, and stroke patient organizations. Conclusion— Existing visual aids for stroke fibrinolysis decision-making have deficiencies. New visual displays are now available to convey the health benefits and risks of fibrinolytic stroke therapy efficiently and informatively to patients and family members.Keywords
This publication has 14 references indexed in Scilit:
- The Effect of Alternative Graphical Displays Used to Present the Benefits of Antibiotics for Sore Throat on Decisions about Whether to Seek Treatment: A Randomized TrialPLOS Medicine, 2009
- Treatment Time-Specific Number Needed to Treat Estimates for Tissue Plasminogen Activator Therapy in Acute Stroke Based on Shifts Over the Entire Range of the Modified Rankin ScaleStroke, 2009
- Novel End Point Analytic Techniques and Interpreting Shifts Across the Entire Range of Outcome Scales in Acute Stroke TrialsStroke, 2007
- Numeric, Verbal, and Visual Formats of Conveying Health Risks: Suggested Best Practices and Future RecommendationsMedical Decision Making, 2007
- Thrombolytic Therapy for Acute Ischemic StrokeStroke, 2007
- The Stroke–Thrombolytic Predictive InstrumentStroke, 2006
- Design Features of Graphs in Health Risk Communication: A Systematic ReviewJournal of the American Medical Informatics Association, 2006
- Developing a quality criteria framework for patient decision aids: online international Delphi consensus processBMJ, 2006
- Are humans good intuitive statisticians after all? Rethinking some conclusions from the literature on judgment under uncertaintyCognition, 1996
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995